What is Bluejay Therapeutics worth?
$820.0Mlast known valuation
Bluejay Therapeutics last raised $182.0M in its Later Stage VC (Series C) (May 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Bluejay Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2024 | Later Stage VC (Series C) | $182.0M | ▮ | ▮ |
| Aug 2022 | Early Stage VC | $20.5M | ▮ | ▮ |
| Jun 2021 | Early Stage VC | $19.2M | ▮ | ▮ |
How Bluejay Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Bluejay Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Bluejay Therapeutics worth?
- Bluejay Therapeutics's last known valuation is $820.0M.
- How much has Bluejay Therapeutics raised?
- Bluejay Therapeutics has raised $243.0M in total funding across 3 recorded rounds.
- When did Bluejay Therapeutics last raise?
- Bluejay Therapeutics last raised in May 2024 (Later Stage VC (Series C)), raising $182.0M.